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TRAIL amplifies FasL-induced hepatocyte apoptosis in vitro. Isolated 
murine hepatocytes were treated with increasing concentrations of 
soluble Fc-FasL (A) or TRAIL (B) or pretreated with or without TRAIL 
(30 ng/ml) prior to induction of apoptosis with serial dilutions of soluble 
FasL from Neuro-2 cells (C). Mean values of quadruplicates ± SD of 1 
representative experiment out of 3 are shown.
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Attenuated Fas-induced liver damage in TRAIL-deficient mice. Wild-type or TRAIL-deficient mice were injected i.v. with PBS as a control or 
anti-Fas antibody. Liver tissue and serum samples of mice still alive after 4 hours were isolated and analyzed. (A) Macroscopic analysis of 
intact liver from untreated wild-type (TRAIL+/+) mice and anti-Fas–injected wild-type and TRAIL-deficient (TRAIL–/–) mice. The liver of anti-
Fas–treated wild-type mice is hemorrhagic and necrotic. (B) Serum levels of liver transaminase (AST) in control (PBS) or anti-Fas–treated 
wild-type or TRAIL-deficient mice. One representative experiment out of 3 is shown. n = 4 mice per group, mean ± SD. *P < 0.01, Student’s 
t test. (C) Histological analysis of liver sections from untreated wild-type (TRAIL+/+, control), anti-Fas–treated wild-type, and TRAIL-deficient 
mice. Low- and high-power magnification of representative samples is shown. (D) Immunohistochemistry for active caspase 3 (Casp 3). Cas-
pase 3–positive apoptotic cells are stained in red. (E) Detection of caspase 3 activation in control-treated or anti-Fas–treated liver samples from 
wild-type or TRAIL-deficient mice by Western blot. The 18-kDa fragment indicates caspase cleavage and activation. Samples from 1 control 
and 4 anti-Fas–treated mice are shown.
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TRAIL accelerates anti-Fas–induced lethality. Survival curve of anti-
Fas–treated wild-type (TRAIL+/+) and TRAIL-deficient (TRAIL–/–) mice 
over 24 hours.One representative experiment out of 2 is shown. n = 7 
mice per group.
Figure 4
Role of JNK in TRAIL-mediated sensitization of Fas-induced apopto-
sis. (A) Wild-type (TRAIL+/+) or TRAIL-deficient mice (TRAIL–/–) were 
injected with PBS or anti-Fas antibody and euthanized at indicated 
time points. Liver protein samples were analyzed for phospho-JNK 
(p-JNK), active caspase 3, and JNK as loading control. Two mice per 
group are shown. (B) Serum transaminase levels (AST) were ana-
lyzed in wild-type and TRAIL-deficient mice at indicated time points 
after anti-Fas injection. Mean values ± SD of 3 mice per group are 
shown. (C) Wild-type mice were injected i.p. with control or JNK inhibi-
tor SP600125 (inh) prior to injection of anti-Fas antibody. Serum trans-
aminase levels (AST) were analyzed after 4 hours. Bars represent 
mean values ± SD of 7 mice per group. Statistical differences were 
analyzed by Student’s t test. *P < 0.01.
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In vitro cell death assay. Murine hepatocytes were isolated by perfusion of 
liver lobes with Ca2+- and Mg2+-free HEPES buffer, followed by HEPES buf-
Figure 5
Role of Bim in TRAIL-mediated sensitization of Fas-induced 
apoptosis. (A) Wild-type or TRAIL-deficient mice were treated 
as in Figure 4A (identical samples), and liver protein samples 
were analyzed for BimEL and JNK as loading control. (B) Dephos-
phorylation of BimEL by calf intestinal phosphatase (CIAP). Liver 
protein samples from control or anti-Fas–injected mice were 
treated with or without calf intestinal phosphatase, and BimEL 
was detected by Western blot. (C) Wild-type mice were treated 
with JNK inhibitor and anti-Fas as in Figure 4B, and liver protein 
samples were analyzed by Western blot for BimEL, p-JNK, active 
caspase 3, and JNK as loading control. Two mice per group are 
shown. n = 7 per group.
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Bim is required for anti-Fas–induced liver damage. (A) Wild-type, Bim heterozygous (Bim+/–), 
Bim homozygous–deficient (Bim–/–), TRAIL-deficient (TRAIL–/–), and TRAIL×Bim double-
deficient mice (TRAIL–/–×Bim–/–) were injected with anti-Fas antibody, and serum transami-
nase levels (AST) were analyzed after 4 hours. Mean values ± SD of 4 mice per group are 
shown. (B) Histological analysis of liver sections from untreated wild-type mice (Bim+/+) or 
anti-Fas–treated wild-type and Bim-deficient mice (Bim–/–). Low- and high-power magnifi-
cation of representative samples is shown. (C) Immunohistochemical detection of active 
caspase 3 (apoptotic cells, red) in control-treated wild-type mice (Bim+/+) or anti-Fas–treated 
wild-type or Bim-deficient mice (Bim–/–). (D) Hepatocytes isolated from wild-type (Bim+/+) 
and Bim-deficient (Bim–/–) mice were pretreated with buffer control or 30 ng/ml TRAIL prior 
to apoptosis induction with increasing concentrations of soluble Fc-FasL. Mean values ± SD 
of quadruplicates of 1 representative experiment out of 3 are shown. *P < 0.05, Student’s 
t test, Bim+/+ with or without TRAIL. (E) Western blot analysis of liver extracts from wild-type, 
TRAIL-deficient (TRAIL–/–), and Bim-deficient (Bim–/–) mice (2 mice per group). Expression 
levels of Fas, caspase 8, Bid, BimEL, caspase 3, and JNK as loading control are shown.
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